JP2008543956A5 - - Google Patents

Download PDF

Info

Publication number
JP2008543956A5
JP2008543956A5 JP2008518659A JP2008518659A JP2008543956A5 JP 2008543956 A5 JP2008543956 A5 JP 2008543956A5 JP 2008518659 A JP2008518659 A JP 2008518659A JP 2008518659 A JP2008518659 A JP 2008518659A JP 2008543956 A5 JP2008543956 A5 JP 2008543956A5
Authority
JP
Japan
Prior art keywords
tfa
acn
oxadiazolyl
ymc
thiadiazolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008518659A
Other languages
English (en)
Japanese (ja)
Other versions
JP5097701B2 (ja
JP2008543956A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/005648 external-priority patent/WO2007000240A1/en
Publication of JP2008543956A publication Critical patent/JP2008543956A/ja
Publication of JP2008543956A5 publication Critical patent/JP2008543956A5/ja
Application granted granted Critical
Publication of JP5097701B2 publication Critical patent/JP5097701B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008518659A 2005-06-28 2006-06-13 Ｒｈｏ−キナーゼの阻害剤としてのイソキノリン誘導体 Expired - Fee Related JP5097701B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05013868 2005-06-28
EP05013868.4 2005-06-28
PCT/EP2006/005648 WO2007000240A1 (en) 2005-06-28 2006-06-13 Isoquinoline derivatives as inhibitors of rho-kinase

Publications (3)

Publication Number Publication Date
JP2008543956A JP2008543956A (ja) 2008-12-04
JP2008543956A5 true JP2008543956A5 (enExample) 2009-07-30
JP5097701B2 JP5097701B2 (ja) 2012-12-12

Family

ID=35395794

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008518659A Expired - Fee Related JP5097701B2 (ja) 2005-06-28 2006-06-13 Ｒｈｏ−キナーゼの阻害剤としてのイソキノリン誘導体

Country Status (33)

Country Link
US (2) US8501736B2 (enExample)
EP (1) EP1899322B1 (enExample)
JP (1) JP5097701B2 (enExample)
KR (1) KR101327780B1 (enExample)
CN (1) CN101213187B (enExample)
AR (1) AR054518A1 (enExample)
AT (1) ATE441641T1 (enExample)
AU (1) AU2006264043B2 (enExample)
BR (1) BRPI0613597A2 (enExample)
CA (1) CA2611295C (enExample)
CY (1) CY1110108T1 (enExample)
DE (1) DE602006008945D1 (enExample)
DK (1) DK1899322T3 (enExample)
DO (1) DOP2006000149A (enExample)
ES (1) ES2331853T3 (enExample)
GT (1) GT200600273A (enExample)
HR (1) HRP20090589T1 (enExample)
IL (1) IL188380A (enExample)
MA (1) MA29535B1 (enExample)
MX (1) MX2008000017A (enExample)
MY (1) MY146037A (enExample)
NZ (1) NZ565040A (enExample)
PA (1) PA8683501A1 (enExample)
PE (1) PE20070141A1 (enExample)
PL (1) PL1899322T3 (enExample)
PT (1) PT1899322E (enExample)
RS (1) RS51139B (enExample)
RU (1) RU2443688C2 (enExample)
SI (1) SI1899322T1 (enExample)
TW (1) TWI372756B (enExample)
UY (1) UY29641A1 (enExample)
WO (1) WO2007000240A1 (enExample)
ZA (1) ZA200710001B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7998978B2 (en) 2006-05-01 2011-08-16 Pfizer Inc. Substituted 2-amino-fused heterocyclic compounds
JP5405316B2 (ja) 2006-12-27 2014-02-05 サノフイ シクロアルキルアミン置換イソキノリン誘導体
MY150746A (en) 2006-12-27 2014-02-28 Sanofi Aventis Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase
DE602007013950D1 (de) * 2006-12-27 2011-05-26 Sanofi Aventis Cycloalkylaminsubstituierte isochinolon- und isochinolinonderivate
KR101545533B1 (ko) * 2006-12-27 2015-08-19 사노피 치환된 이소퀴놀린 및 Ｒｈｏ-키나아제 억제제로서의 이의 용도
GB0719644D0 (en) 2007-10-05 2007-11-14 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB0803018D0 (en) * 2008-02-19 2008-03-26 Cancer Rec Tech Ltd Therapeutic compounds and their use
HUE026617T2 (en) * 2008-06-24 2016-06-28 Sanofi Sa Substituted isoquinolines and isoquinolinones as RHO kinase inhibitors
WO2009156099A1 (en) * 2008-06-24 2009-12-30 Sanofi-Aventis 6-substituted isoquinolines and isoquinolinones
ES2434121T3 (es) * 2008-06-24 2013-12-13 Sanofi Derivados de isoquinolina e isoquinolinona bi- y policíclicos sustituidos como inhibidores de rho cinasa
GB0812969D0 (en) * 2008-07-15 2008-08-20 Sentinel Oncology Ltd Pharmaceutical compounds
KR101323448B1 (ko) 2008-10-02 2013-11-27 아사히 가세이 파마 가부시키가이샤 ８위 치환 이소퀴놀린 유도체 및 이의 용도
EP2177218A1 (en) 2008-10-15 2010-04-21 Medizinische Universität Wien Regenerative therapy
JP5391372B2 (ja) * 2009-07-08 2014-01-15 公益財団法人名古屋産業科学研究所 芳香族アミン化合物の製造方法
RU2012146246A (ru) * 2010-03-31 2014-05-10 Актелион Фармасьютиклз Лтд Антибактериальные производные изохинолин-3-илмочевины
CA2817460A1 (en) 2010-12-17 2012-06-21 F. Hoffmann-La Roche Ag Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
GB201104267D0 (en) 2011-03-14 2011-04-27 Cancer Rec Tech Ltd Pyrrolopyridineamino derivatives
BR112014010938A2 (pt) 2011-11-09 2017-05-16 Cancer Res Tech Ltd compostos de 5-(piridin-2-il-amino)-pirazina-2-carbonitrila e seu uso terapêutico
PL2855448T3 (pl) 2012-05-15 2017-09-29 Cancer Research Technology Ltd 5-[[4-[[morfolino-2-ilo]metyloamino]-5-(trifluorometylo)-2-pirydylo]amino]pirazyno-2-karbonitryl i jego zastosowanie terapeutyczne
GB201216017D0 (en) 2012-09-07 2012-10-24 Cancer Rec Tech Ltd Inhibitor compounds
GB201216018D0 (en) 2012-09-07 2012-10-24 Cancer Rec Tech Ltd Pharmacologically active compounds
PL3027600T3 (pl) 2013-07-31 2022-08-08 Novartis Ag 1,4-dwupodstawione pochodne pirydazyny i ich zastosowanie do leczenia stanów związanych z niedoborem smn
FR3017868A1 (fr) * 2014-02-21 2015-08-28 Servier Lab Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB201403536D0 (en) 2014-02-28 2014-04-16 Cancer Rec Tech Ltd Inhibitor compounds
TWI699355B (zh) 2014-12-24 2020-07-21 美商基利科學股份有限公司 喹唑啉化合物
BR112017013491A2 (pt) 2014-12-24 2018-01-09 Gilead Sciences, Inc. compostos de pirimidina fundida para o tratamento de hiv
NZ733125A (en) 2014-12-24 2018-06-29 Gilead Sciences Inc Isoquinoline compounds for the treatment of hiv
MA48994A (fr) 2017-03-30 2020-02-05 Hoffmann La Roche Isoquinoléines utilisées en tant qu'inhibiteurs de hpk1
GB201709840D0 (en) 2017-06-20 2017-08-02 Inst Of Cancer Research: Royal Cancer Hospital Methods and medical uses
US10696638B2 (en) 2017-12-26 2020-06-30 Industrial Technology Research Institute Compounds for inhibiting AGC kinase and pharmaceutical compositions comprising the same
CN110117278B (zh) * 2018-02-07 2022-07-19 石家庄以岭药业股份有限公司 烷氧基苯并五元(六元)杂环胺类化合物及其药物用途
CN112839647B (zh) * 2018-06-07 2025-09-23 达萨玛治疗公司 Sarm1抑制剂
JP7386841B2 (ja) * 2018-07-24 2023-11-27 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト イソキノリン化合物及びその使用
TW202024053A (zh) 2018-10-02 2020-07-01 美商建南德克公司 異喹啉化合物及其用途
US11612606B2 (en) 2018-10-03 2023-03-28 Genentech, Inc. 8-aminoisoquinoline compounds and uses thereof
CN110407777B (zh) * 2019-08-15 2022-09-09 湖北远大富驰医药化工股份有限公司 一种呋虫胺的合成方法
CN111574413B (zh) * 2020-06-08 2022-04-05 杭州尚合生物医药科技有限公司 一种2-氨甲基吡啶与dmf-dma作为胺源的磺酰脒的制备方法
CN113372341A (zh) * 2021-07-02 2021-09-10 黄淮学院 三氟醋酸二氢异喹啉衍生物的合成方法及装置

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485537B2 (fr) 1977-04-13 1986-05-16 Anvar Dipyrido(4,3-b)(3,4-f)indoles, procede d'obtention, application therapeutique et compositions pharmaceutiques les contenant
WO1992002476A1 (en) 1990-07-31 1992-02-20 E.I. Du Pont De Nemours And Company Catalytic equilibration of selected halocarbons
US5480883A (en) * 1991-05-10 1996-01-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
GB9516709D0 (en) 1995-08-15 1995-10-18 Zeneca Ltd Medicament
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
BR9711154A (pt) * 1996-08-12 1999-08-17 Yoshitomi Pharmaceutical Agente farmac-utico contendo inibidor cinase rho
JPH1087629A (ja) 1996-09-18 1998-04-07 Fujisawa Pharmaceut Co Ltd 新規イソキノリン誘導体、およびその医薬用途
AU8872198A (en) 1997-08-29 1999-03-22 Zeneca Limited Aminometyl oxooxazolidinyl benzene derivatives
TW575567B (en) 1998-10-23 2004-02-11 Akzo Nobel Nv Serine protease inhibitor
GB9912701D0 (en) 1999-06-01 1999-08-04 Smithkline Beecham Plc Novel compounds
US6541456B1 (en) 1999-12-01 2003-04-01 Isis Pharmaceuticals, Inc. Antimicrobial 2-deoxystreptamine compounds
IL150650A0 (en) * 2000-01-20 2003-02-12 Eisai Co Ltd Piperidine derivatives and pharmaceutical compositions containing the same
US7217722B2 (en) * 2000-02-01 2007-05-15 Kirin Beer Kabushiki Kaisha Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
WO2001064238A2 (en) 2000-02-29 2001-09-07 Curis, Inc. Methods and compositions for regulating adipocytes
GB0004887D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
AR033517A1 (es) 2000-04-08 2003-12-26 Astrazeneca Ab Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
GB0013060D0 (en) 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
WO2002034712A1 (en) 2000-10-27 2002-05-02 Takeda Chemical Industries, Ltd. Process for preparing substituted aromatic compounds and intermediates therefor
US20040077654A1 (en) 2001-01-15 2004-04-22 Bouillot Anne Marie Jeanne Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
SE0101038D0 (sv) 2001-03-23 2001-03-23 Astrazeneca Ab Novel compounds
PE20021011A1 (es) 2001-03-23 2003-02-01 Bayer Corp Derivados quinazolinicos como inhibidores de la rho-quinasa
AU2002256418A1 (en) 2001-04-27 2002-11-11 Vertex Pharmaceuticals Incorporated Inhibitors of bace
JPWO2002100833A1 (ja) * 2001-06-12 2004-09-24 住友製薬株式会社 Ｒｈｏキナーゼ阻害剤
GB0117899D0 (en) 2001-07-23 2001-09-12 Astrazeneca Ab Chemical compounds
WO2003024450A1 (en) 2001-09-20 2003-03-27 Eisai Co., Ltd. Methods for treating prion diseases
SE0104340D0 (sv) 2001-12-20 2001-12-20 Astrazeneca Ab New compounds
EP1541559A4 (en) * 2002-07-22 2007-08-22 Asahi Kasei Pharma Corp 5-SUBSTITUTED ISOQUINOLINE DERIVATIVE
US7615564B2 (en) 2002-09-12 2009-11-10 Kirin Beer Kabushiki Kaisha Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
WO2004106325A1 (en) 2003-05-29 2004-12-09 Schering Aktiengesellschaft Prodrugs of 1-(1-hydroxy-5-isoquinolinesulfonyl)homopiperazine
US20070021404A1 (en) 2003-06-24 2007-01-25 Dan Peters Novel aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
CA2539479C (en) 2003-09-23 2010-07-06 Merck & Co., Inc. Isoquinoline potassium channel inhibitors
WO2005030791A2 (en) 2003-09-23 2005-04-07 Merck & Co., Inc. Isoquinolinone potassium channel inhibitors
US20050067037A1 (en) 2003-09-30 2005-03-31 Conocophillips Company Collapse resistant composite riser
WO2005035516A1 (ja) 2003-10-10 2005-04-21 Ono Pharmaceutical Co., Ltd. 新規縮合複素環化合物およびその用途
WO2005054202A1 (en) 2003-11-25 2005-06-16 Eli Lilly And Company 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (proteinkinase b)
JP2005232175A (ja) * 2004-01-21 2005-09-02 Asahi Kasei Pharma Kk ５−置換イソキノリン医薬
WO2005074535A2 (en) 2004-01-30 2005-08-18 Eisai Co., Ltd. Cholinesterase inhibitors for spinal cord disorders
EP1729761A4 (en) 2004-03-05 2008-09-03 Eisai Co Ltd TREATMENT OF CADASIL WITH CHOLINESTERASE INHIBITORS
SE0400850D0 (sv) 2004-03-30 2004-03-31 Astrazeneca Ab Novel Compounds
US7517991B2 (en) * 2004-10-12 2009-04-14 Bristol-Myers Squibb Company N-sulfonylpiperidine cannabinoid receptor 1 antagonists
UA93882C2 (ru) 2005-07-26 2011-03-25 Санофи-Авентис Пиперидинил-замещенные производные изохинолона kak ингибиторы rho-киназы
JP5049970B2 (ja) 2005-07-26 2012-10-17 サノフイ Ｒｈｏ−キナーゼ阻害剤としてのシクロヘキシルアミンイソキノロン誘導体
TW200745101A (en) 2005-09-30 2007-12-16 Organon Nv 9-Azabicyclo[3.3.1]nonane derivatives
JP4033221B2 (ja) 2005-12-02 2008-01-16 ダイキン工業株式会社 冷媒加熱装置
TW200738682A (en) 2005-12-08 2007-10-16 Organon Nv Isoquinoline derivatives
US7618985B2 (en) * 2005-12-08 2009-11-17 N.V. Organon Isoquinoline derivatives
US7893088B2 (en) * 2006-08-18 2011-02-22 N.V. Organon 6-substituted isoquinoline derivatives
WO2008077556A1 (en) 2006-12-27 2008-07-03 Sanofi-Aventis Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives
KR101545533B1 (ko) 2006-12-27 2015-08-19 사노피 치환된 이소퀴놀린 및 Ｒｈｏ-키나아제 억제제로서의 이의 용도

Similar Documents

Publication Publication Date Title
JP2008543956A5 (enExample)
JP2006528601A5 (enExample)
JP2010514715A5 (enExample)
JP2010514717A5 (enExample)
ES2632009T3 (es) Ligandos de receptores de opioides y métodos para utilizar y obtener los mismos
ES2600161T3 (es) Compuestos para uso en el tratamiento de enfermedades mediadas por linfocitos T
JP2010514718A5 (enExample)
RU2125047C1 (ru) N-производные хинолина или их аддитивные соли с неорганическими и органическими кислотами или с неорганическими и органическими основаниями, способы их получения и фармацевтическая композиция на их основе
JP2010514720A5 (enExample)
JP2010514719A5 (enExample)
AU2018306444A1 (en) TYK2 inhibitors and uses thereof
ES2397934T3 (es) Compuestos de aminopiridina y carboxipiridina como inhibidores de fosfodiesterasa 10
SA01220441B1 (ar) المركبات عديدة الكربوكسي أميدات polyarylcarboxamides كعوامل خافضة للدهون lipid lowering agents
TW406075B (en) Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
TW201139406A (en) Voltage-gated sodium channel blockers
CN106458956B (zh) 杂芳基取代的杂环基砜
BRPI0713576A2 (pt) composto, formulação farmacêutica, uso de um composto, e, métodos para prevenir e/ou tratar condição, distúrbio e doença, para aumentar a formação óssea, para aumentar a formação óssea de estrutura esponjosa e/ou nova formação óssea, para aumentar a densidade mineral óssea, para reduzir a incidência de fratura e para melhorar a cicatrização de fratura, e, processo para preparar um composto
BR112019009293A2 (pt) pirrol amidas como inibidores de integrina alfa v
AU2015291477B2 (en) Novel 2,5-substituted pyrimidines as PDE inhibitors
CN102030750A (zh) 用作CB1受体配体的新四氢-1H-吡啶并[4,3-b]吲哚衍生物
AU2005205090A1 (en) Indole derivatives and use thereof as kinase inhibitors in particular IKK2 inhibitors
CN104854092A (zh) 可用作cb2激动剂的吡啶-2-酰胺类
CN105085528A (zh) 作为二肽基肽酶-iv抑制剂的氨基四氢吡喃衍生物
TW201529574A (zh) 磺醯胺衍生物及其醫藥用途
JP2008543957A5 (enExample)